Abstract
The 5-hydroxytryptamine (5-HT; serotonin)4 receptor is one of three 5-HT receptor subtypes that couple positively to adenylyl cyclase, the others being the 5-HT6 and 5-HT7 receptors [1]. In terms of sequence homology and pharmacology, these receptors are distinct and have differing distributions and function. In the last 5 years or so, the 5-HT4 receptor has become the focus of much interest in both academia and the pharmaceutical industry. Elucidation of the role of the receptor in the central and peripheral nervous systems is thus emerging, and novel therapeutics with 5-HT4 receptor selectivity are currently in advanced clinical trials.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
T.A. Branchek: Semin. Neurol. 7, 375–382 (1996).
S.S. Hegde and R.M. Eglen: FASEB J. 10 1398–1407 (1996).
A. Shenker, S. Maayani, H. Weinstein and IP. Green: Eur. J. Pharmacol. 109 427–429 (1985).
A. Dumuis, R. Bouhelal, M. Sebben and J. Bockaert: Eur. J. Pharmacol. 146 187–188 (1988).
A. Dumuis, R. Bouhelal, M. Sebben, R. Cory and J. Bockaert: Mol. Pharmacol. 34 880–887 (1988).
C. Gerald, N. Adham, H.-T. Kao, M.A. Olsen, T.M. Laz, L.E. Schecter, J.A. Bard, P.J.-J. Vaysse, P.R. Hartig, T.A. Branchek and R.L. Weinshank: EMBO J. 14 2806–2815 (1995).
L.M. Gaster and F.D. King: Med. Res. Rev. 17 163–214 (1997).
R.M. Eglen, E.H.F. Wong, A. Dumuis and J. Bockaert: Trends Pharmacol. Sci. 16, 391–398 (1995).
R.M. Eglen and S.S. Hegde: Exp. Opin. Invest. Drugs 5, 373–388 (1996).
A.P.D.W. Ford and D.E. Clarke: Med. Res. Rev. 13, 633–662 (1993).
International patent number WO 94/14957.
S. Claeysen, M. Sebben, L. Journot, J. Bockaert and A. Dumuis: FEBS Lett. 398, 19–25 (1996).
N. Adham, C. Gerald, L. Schecter, P. Vaysse, R. Weinshank and T. Branchek: Eur. J. Pharmacol. 304, 231–235 (1996).
H. Ansanay, M. Sebben, J. Bockaert and A. Dumuis: Eur. J. Pharmacol. 298, 165–174 (1996).
E. Monferini, P. Gaetani, R. Rodriguez y Baena, E. Giraldo, M. Parenti, A. Zocchetti and C.A Rizzi: Life Sci. 52, PL61–65 (1993).
M. Langlois, L. Zhang, D. Yang, B. Bremont, S. Shen, L. Manara and T. Croci: Bio-organ. Med. Chem. Lett. 4, 1433–1436 (1994).
D. Yang, J.-L. Soulier, S. Sacsic, M. Mathe-Allainmat, B. Bremont, T. Croci, R. Car-damone, G. Aureggi and M. Langlois: J. Med. Chem. 40, 608–621 (1997).
R.D. Clark, A. Jahangir, J.A. Langston, K.K. Weinhardt, A.B. Miller, E. Leung and R.M. Eglen: Bioorgan. Med. Chem. Lett. 4, 2477–2480 (1994).
R.M. Eglen, D.W. Bonhaus, L.G. Johnson, E. Leung and R.D. Clark: Br. I Pharmacol. 115, 1387–1392 (1995).
J.D. Gale, C.J. Grossman, J.W. Whitehead, A.W. Oxford, K.T. Bunce and P.P. Humphrey: Br. J. Pharmacol. 111, 332–338 (1994).
K.A. Wardle, E.S. Elliss, G.S. Baxter, G.A. Kennett, L.M. Gaster and G.J. Sanger: Br. J. Pharmacol. 112, 789–794 (1994).
J. Gale, A. Green, R.S. Sargent, N.M. Clayton and K.T. Bunce: Br. J. Pharmacol. 773, 119P.
L.M. Gaster, G.E Joiner, F.D. King, P.A. Wyman, J.M. Sutton, S. Bingham, E.S. Ellis, G.J. Sanger and K.A. Wardle: J. Med. Chem. 38, 4760–4763 (1995).
K.A. Wardle, S. Bingham, E.S. Ellis, L.M. Gaster, B. Rushant, M.I. Smith and G.J. Sanger: Br. J. Pharmacol. 118, 665–670 (1996).
S.S Hegde, D.W. Bonhaus, L.G. Johnson, E. Leung, R.D. Clark and R.M. Eglen: Br. J. Pharmacol. 115, 1087–1095 (1995).
R.D. Clark, A. Jahangir, L.A. Flippen, A.B. Miller, E. Leung, D.W. Bonhaus, E.H.E Wong and R.M. Eglen: Bioorgan. Med. Chem. Lett. 5, 2119–2122 (1995).
A.J. Kaumann: Trends Pharmacol. Sci. 75, 451–455 (1994).
E. Leung, M.T. Pulido-Rios, D.W. Bonhaus, L.A. Perkins, K.D. Zeitung, S.A.O. Hsu, R.D. Clark, E.H.F. Wong and R.M. Eglen: Naunyn Schmiedebergs Arch. Pharmacol. 354, 145–156 (1996).
C. Ullmer, P. Engels, S. Abdel’Al and H. Lubbert: Naunyn Schmiedebergs Arch. Pharmacol. 354, 210–212 (1996).
M.T. Vilaro, R. Cortes, C. Gerald, T.A. Branchek, J.M. Palacios and G. Mengod: Mol. Brain Res. 43, 356–360 (1996).
C.J. Grossman, G.J. Kilpatrick and K.T. Bunce: Br. J. Pharmacol. 109, 618–624 (1993).
A.J. Kaumann, J.A. Lynham and A. Brown: Br. J. Pharmacol. 115, 933–936 (1995).
C. Waeber, M. Sebben, A. Nieoullon, J. Bockaert and A. Dumuis: Neuropharmacol. 53, 527–541 (1994).
T. Domenech, J. Beleta, A.G. Fernandez, R.W. Gristwood, F. Cruz Sachez, E. Tolosa and J.M. Palacios: Mol. Brain Res. 21, 17–180 (1994).
L.B. Jakeman, Z.P. To, R.M. Eglen, E.H.F. Wong and D.W. Bonhaus: Neuropharmacol. 33, 1027–1038 (1994).
V. Compan, A. Dazuta, P. Salin, M. Sebben, UJ. Bockaert and A. Dumuis: Eur. J. Neurosci. 8, 2591–2598 (1996).
G.B. Schiavi, S. Brunet, C.A. Rizzi and H. Ladinsky: Neuropharmacol. 33, 543–549 (1994).
Y. Uchiyama-Tsuyuki, M. Saitoh and M. Muramatsu: Life Sci. 59, 2129–2137 (1996).
G.P. Reynolds, S.L. Mason, A. Meldrum, S. De Keczer, H. Parnes, R.M. Eglen and E.H.F. Wong: Br. J. Pharmacol. 114, 993–998 (1995).
S. Benloucif, M.J. Keegan and M.P. Galloway: J. Pharm Exp.Ther. 265, 373–377 (1993).
G.J. Kilpatrick, R.M. Hagan and J.D. Gale: Behav. Brain Res. 73, 11–13 (1996).
N. Bonhomme, P. De Deurwaerdere, M. Le Moal and U. Spampinato: Neuropharmacol. 34, 269–279 (1995).
L.J. Steward, J. Ge, R.L. Stowe, D.C. Brown, R.K. Brunton, PR. Stokes and N.M. Barnes: Br. J. Pharmacol. 117, 55–62 (1996).
P. De Deurwaerdere, M. Bonhomme, G. Lucas, A. Cheramy and U. Spampinato: J. Neurochem. 68, 195–203 (1997).
L. Pozzi, L. Trabaee, R. Invernizzi and R. Samanin: Brain Res. 692, 265–268 (1995).
C. Reavill, J.P. Hatcher, T.S.C. Zetterstrom, V.A. Lewis, G.J. Sänger, J.J. Hagan and S. McKay: Br. I Pharmacol. 118, 71P (1996).
A.P. Sempere, J. Duarte, C. Cabezas, L.E. Claveria and F. Coria: Clin. Neurophar-maeol. 18, 76–78 (1995).
J. Ge and N.M. Barnes: Br. J. Pharmacol. 117, 1475–1480 (1996).
H. Kilbinger, A. Gerbauer, J. Haas, H. Ladinsky and C.A. Rizzi: Naunyn Schmiedebergs Arch. Pharmacol. 351, 229–236 (1995).
S. Consolo, S. Arnaboldi, S. Giorgi, G. Russi and H. Ladinsky: Neuroreport 5, 1230–1232 (1994).
H.G.W.M. Boddeke and H.O. Kakman: Br. J. Pharmacol. 101, 281–284 (1990).
R. Andrade and Y. Chaput: J. Pharmacol. Exp. Ther. 257, 930–937 (1991).
G.E. Torres, I.L. Holt and R. Andrade: J. Pharmacol. Exp. Ther. 271, 255–261 (1994).
G.E. Torres, Y. Chaput and R. Andrade: Mol. Pharmacol. 47, 191–197 (1995).
S. Rowchowdhury, H. Haas and E.G. Anderson: Neuropharmacol. 33, 551–557 (1994).
M. Bijak, K. Tokarski and J. Maj: Naunyn Schmiedebergs Arch. Pharmacol. 355, 14–19 (1997).
M. Simizu, A. Nishida, H. Fukuda, H. Saito and S. Yamawaki: Br. J. Pharmacol. 114, 1282–1288 (1995).
E.R. Kandel and J.H. Schwartz: Science 218, 433–438 (1982).
R. Bourtchuladze, B. Frenguelli, J. Blendy, D. Cioffi, G. Schultz and A. Silva: Cell 79, 59–68 (1994).
H. Ansanay, A. Dumuis, M. Sebben, J. Bockaert and J. Fagni: Proc. Natl. Acad. Sci. USA 92, 6635–6639 (1995).
D.J. Fontana, S. Daniels, C. Henderson, R.M. Eglen and E.H.F. Wong: 3rd IUPHAR Satellite on Serotonin, Chicago, 30 July-3 August, abstract no. 5 (1994).
C. Ghelardini, P. Meoni, N. Galeotti, P. Malmberg-Aiello, C.A. Rizzi and A. Barto-lini: 3rd IUPHAR Satellite on Serotonin, Chicago, 30 July-3 August, abstract no. 1 (1994).
D.J. Fontana, S. Daniels, E.H.F. Wong, R.D. Clark and R.M. Eglen: Neuropharmacol. (in press) (1997).
S. Letty, R. Child, A. Dumuis, A. Pantaloni, J. Bockaert and G. Rondouin: Neuropharmacol. (in press) (1997).
S. Birstiel and S.G. Beck: J. Pharmacol. Exp. Ther. 273, 1132–1138 (1995).
V. Contesse, C. Hamel, C. Delarue, H. Lefebvre and H. Vaudry: Eur. J. Pharmacol. 265, 27–33 (1994).
C.H. Cheng, B. Costall, M.E. Kelly and R.J. Naylor: Eur. J. Pharmacol. 255, 39–49 (1994).
B. Costall and R.J. Naylor: Br. J. Pharmacol. 119, 348P (1996).
B. Costall and R.J. Naylor: Br. J. Pharmacol. 119, 352P (1996).
B. Costall and R.J. Naylor: Int. Clin. Psychopharmacol. 8, 11–18 (1993).
IS. Silvestre, A.G. Fernandez and J.M. Palacios: Eur. J. Pharmacol. 309, 219–222 (1996).
G.A. Kennett, F. Bright, B. Trail, T.P. Blackburn and G.J. Sanger: Br. J. Pharmacol. 120, 138P (1997).
N. Andrews and S.E. File: Eur. J. Pharmacol. 235, 109–112 (1993).
C. Ghelardini, N. Galeotti, F. Casamenti, P. Malmberg-Aiello, G. Pepeu, F. Gaultieri and A. Bartolini: Life Sci. 58, 2297–2309 (1996).
M.N. Romanelli, A. Bartolini, C. Bertucci, S. Dei, C. Ghelardini, M.G. Giovannini, F Gaultieri, G. Pepeu, S. Sepecchi and E. Teodori: Chirality 8, 225–233 (1996).
G.J. Sanger: Neurogastroenterol. Motil. 8, 319–331 (1996).
C.W. Hodge, J.S. Neihus and H.H. Samson: Psychopharmacol. 119, 186–192 (1995).
I. Panocka, R. Ciccocioppo, C. Polodori, P. Pompei and M. Massi: Pharmacol. Bio-chem. Behav. 52, 255–259 (1995).
C.M. Villalon, J.A. Terron, E. Ramirez-San Juan and P.R. Saxena: Arch. Med. Res., 26, 331–344 (1995).
J.J. Lucas and R. Hen: Trends Pharmacol. Sci. 16, 246–252 (1995).
J. Bockaert, H. Ansanay, C. Waeber, M. Sebben, L. Fagni and A. Dumuis: CNS Drugs 7, 6–15 (1994).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Basel AG
About this chapter
Cite this chapter
Eglen, R.M. (1997). 5-Hydroxytryptamine (5-HT)4 receptors and central nervous system function: An update. In: Jucker, E. (eds) Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques. Progress in Drug Research / Fortschritte der Arzneimittelforschung / Progrès des recherches pharmaceutiques, vol 49. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8863-9_1
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8863-9_1
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9807-2
Online ISBN: 978-3-0348-8863-9
eBook Packages: Springer Book Archive